Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,886,077
+$15,886,077 QoQ
Shares Held
62,551
Ownership
0.003%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#860
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$15,500,184
PutShares
63,411
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOGAN CAPITAL MANAGEMENT INC holds $143,017,458 across 13 Drug Manufacturers - General names. JNJ ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,791 | $33,333,361 | |
| 2 | MRK |
Merck & Co., Inc.
|
155,292 | $19,955,022 | |
| 3 | ABBV |
AbbVie Inc.
|
77,182 | $19,422,078 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
62,551 | $15,886,077 | |
| 5 | NVS |
Novartis AG
|
73,584 | $11,532,084 | |
| 6 | SNY |
Sanofi
|
258,642 | $11,033,667 | |
| 7 | PFE |
Pfizer Inc
|
442,396 | $10,652,895 | |
| 8 | GSK |
GSK plc
|
141,076 | $7,395,203 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,886,077 | 62,551 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $15,500,184 | 63,411 | Put | Sole | 2026-05-08 | |
| 2025-12-31 | $15,858,164 | 76,628 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $15,041,641 | 81,122 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $11,823,308 | 77,403 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $17,559,968 | 105,885 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $6,990,352 | 48,336 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,636,591 | 47,122 | Shares | Sole | 2024-12-06 | |
| 2024-06-30 | $6,971,539 | 47,698 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,620,328 | 48,172 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $14,169,452 | 90,401 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,312,802 | 91,896 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,783,987 | 95,360 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,870,855 | 95,941 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,124,274 | 96,939 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,818,622 | 84,590 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,955,926 | 84,254 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $14,808,806 | 83,557 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,188,203 | 82,938 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,515,289 | 83,686 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,451,679 | 81,654 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $13,124,497 | 79,857 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $12,907,677 | 82,016 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $8,953,195 | 60,137 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,341,809 | 80,650 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $8,112,094 | 61,863 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||